Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Daiken Biomedical CoTPE:7780 +0.28%23 9-Day RSI is 44.33 as of Jul. 16, 2026. GuruFocus rates TPE:7780 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review. Among 2,106 Consumer Packaged Goods companies, Daiken Biomedical Co ranks better than 73.03% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Daiken Biomedical Co's 9-Day RSI or its related term are showing as below:
TPE:7780's 9-Day RSI is ranked better than 73.03% of 2106
companies
in the Consumer Packaged Goods industry
Industry Median: 51.685
vs TPE:7780: 44.33
Daiken Biomedical Co (TPE:7780) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Daiken Biomedical Co 9-Day RSI Related Terms
TPE:7780 vs KHC, GIS: 9-Day RSI Comparison
For the Packaged Foods subindustry, Daiken Biomedical Co's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiken Biomedical Co 9-Day RSI vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Daiken Biomedical Co's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Daiken Biomedical Co's 9-Day RSI falls into.
Daiken Biomedical Co (TPE:7780) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiken Biomedical Co (TPE:7780) has a 9-Day RSI of 44.33 as of Jul. 16, 2026. According to the industry distribution chart, Daiken Biomedical Co ranks #568 out of 2106 companies in the Consumer Packaged Goods industry, placing it in the top 27%.
Is Daiken Biomedical Co's 9-Day RSI too high?
Daiken Biomedical Co's current 9-Day RSI is 44.33. The Consumer Packaged Goods industry median 9-Day RSI is 51.69. Daiken Biomedical Co's value of 44.33 is 14.2% below this industry median. Based on the distribution chart, Daiken Biomedical Co ranks #568 out of 2106 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Daiken Biomedical Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Daiken Biomedical Co's 9-Day RSI compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Daiken Biomedical Co ranks #568 out of 2106 companies for 9-Day RSI. This puts Daiken Biomedical Co in the upper half of its industry. The industry median 9-Day RSI is 51.69. Daiken Biomedical Co's value of 44.33 is 14.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Consumer Packaged Goods company?
The median 9-Day RSI among Consumer Packaged Goods companies is 51.69, based on 2,106 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiken Biomedical Co's current 9-Day RSI of 44.33 is 14.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median 9-Day RSI is 51.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiken Biomedical Co's current 9-Day RSI is 44.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Biomedical Co stock overvalued right now?
Daiken Biomedical Co (TPE:7780) has a current 9-Day RSI of 44.33. The current 9-Day RSI is 44.33 and 14.2% below the Consumer Packaged Goods industry median of 51.69. Daiken Biomedical Co's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Daiken Biomedical Co (TPE:7780), the current 9-Day RSI is 44.33 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules. The companies reportable operating segment consists solely of the e-commerce division.
23GF Score
Get the complete analysis for TPE:7780
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:7780 has been successfully added to your 
